Sana Biotechnology, Inc. Common Stock

SANANASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
2.68 USD
↘ 0.28 (9.46%)AT CLOSE (11:59 AM EDT)
2.70
↗ 0.02 (0.75%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
2.70
↗ 0.02 (0.75%)
🔴Market: CLOSED
Open?$2.93
High?$2.95
Low?$2.66
Prev. Close?$2.96
Volume?4.7M
Avg. Volume?3.9M
VWAP?$2.74
Rel. Volume?1.20x
Bid / Ask
Bid?$2.68 × 6.2K
Ask?$2.71 × 5.0K
Spread?$0.03
Midpoint?$2.70
Valuation & Ratios
Market Cap?745.8M
Shares Out?278.3M
Float?158.0M
Float %?58.5%
P/E Ratio?N/A
P/B Ratio?6.25
EPS?-$0.87
Dividend?0.00%
Ex-Dividend?N/A

Shares of Sana Biotechnology, Inc. Common Stock (SANA) are trading at $2.68. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, SANA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Themes
Biotech - Drug Development›Clinical-Stage PlatformsHealthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingHealthcare - Oncology›Cell & Gene Therapy for Cancer
Employees
142
Market Cap
745.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.sana.com
Listed
2021-02-04
Address
188 EAST BLAINE STREET, SUITE 350
SEATTLE, WA
Phone: (206) 701-7914
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
50
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.47Distress
Confidence?56%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?24.36%Squeeze Risk
Short Interest?38.5M
Days to Cover?8.5
Free Float158.0M
Avg Daily Volume4.5M
Settlement Date2026-05-15
Financial Health
Current Ratio?1.25Adequate
Quick Ratio?1.25Adequate
Cash Ratio?0.97Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
29
6.25FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-202.9%WEAK▾
ROA?
S&P
3
-64.8%WEAK▾
Cash Flow & Enterprise
FCF?$-133640000
Enterprise Value?$662.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist